bcl-2 over-expression delays radiation-induced apoptosis without affecting the clonogenic survival of human prostate cancer cells - PubMed (original) (raw)
bcl-2 over-expression delays radiation-induced apoptosis without affecting the clonogenic survival of human prostate cancer cells
N Kyprianou et al. Int J Cancer. 1997.
Abstract
In this study we evaluated the effect of over-expression of the bcl-2 gene, a potent apoptosis suppressor, on radiation-induced apoptotic cell death in 2 human prostate cancer cell lines, androgen-independent PC-3 cells and androgen-sensitive LNCaP cells. Cells were transfected with the bcl-2 gene and bcl-2 transfectant clones isolated under neomycin selection; bcl-2 gene integration and level of mRNA and protein expression in the cloned transfectants were examined by Southern, Northern and Western blot analyses, respectively. Parental, neo control and bcl-2-expressing cells were exposed to single or fractionated doses of ionizing irradiation, and the cellular response to radiation was determined at 24, 48 and 72 hr post-irradiation, on the basis of: (i) loss of cell viability, (ii) clonogenic survival and (iii) induction of apoptotic DNA fragmentation. At 24 hr post-irradiation all cell lines, i.e., parental and bcl-2 transfectants, failed to form colonies, though the majority of bcl-2-expressing cells did not exhibit apoptotic morphology; bcl-2 over-expression in both cell lines reduced apoptosis 48 hr post-irradiation from 20-25% to 5% at a dose of 2,000 cGy. By 72 hr, bcl-2 over-expression afforded a 3-fold protection from radiation-induced apoptosis. There was no significant difference, however, in the clonogenic survival of the parental and bcl-2-expressing cells. Furthermore, there was a 24 hr delay in induction of the apoptosis marker gene SGP-2/TRPM-2 in the bcl-2-expressing cells, co-incidental with the delay in apoptotic DNA fragmentation.
Similar articles
- Radiation-induced apoptosis of human prostate cancer cells is independent of mutant p53 overexpression.
Kyprianou N, Rock S. Kyprianou N, et al. Anticancer Res. 1998 Mar-Apr;18(2A):897-905. Anticancer Res. 1998. PMID: 9615738 - Overexpression of the cytoprotective protein clusterin decreases radiosensitivity in the human LNCaP prostate tumour model.
Zellweger T, Kiyama S, Chi K, Miyake H, Adomat H, Skov K, Gleave ME. Zellweger T, et al. BJU Int. 2003 Sep;92(4):463-9. doi: 10.1046/j.1464-410x.2003.04349.x. BJU Int. 2003. PMID: 12930442 - Dichloroacetate (DCA) sensitizes both wild-type and over expressing Bcl-2 prostate cancer cells in vitro to radiation.
Cao W, Yacoub S, Shiverick KT, Namiki K, Sakai Y, Porvasnik S, Urbanek C, Rosser CJ. Cao W, et al. Prostate. 2008 Aug 1;68(11):1223-31. doi: 10.1002/pros.20788. Prostate. 2008. PMID: 18465755 - Use of antisense oligonucleotides targeting the cytoprotective gene, clusterin, to enhance androgen- and chemo-sensitivity in prostate cancer.
Gleave M, Miyake H. Gleave M, et al. World J Urol. 2005 Feb;23(1):38-46. doi: 10.1007/s00345-004-0474-0. Epub 2005 Jan 26. World J Urol. 2005. PMID: 15770517 Review. - Antisense approaches in prostate cancer.
Chi KN, Gleave ME. Chi KN, et al. Expert Opin Biol Ther. 2004 Jun;4(6):927-36. doi: 10.1517/14712598.4.6.927. Expert Opin Biol Ther. 2004. PMID: 15174974 Review.
Cited by
- Management of locally advanced HPV-related oropharyngeal squamous cell carcinoma: where are we?
Samuels SE, Eisbruch A, Beitler JJ, Corry J, Bradford CR, Saba NF, van den Brekel MW, Smee R, Strojan P, Suárez C, Mendenhall WM, Takes RP, Rodrigo JP, Haigentz M Jr, Rapidis AD, Rinaldo A, Ferlito A. Samuels SE, et al. Eur Arch Otorhinolaryngol. 2016 Oct;273(10):2877-94. doi: 10.1007/s00405-015-3771-x. Epub 2015 Oct 13. Eur Arch Otorhinolaryngol. 2016. PMID: 26463714 Review. - RNA binding motif protein 3 (RBM3) drives radioresistance in nasopharyngeal carcinoma by reducing apoptosis via the PI3K/AKT/Bcl-2 signaling pathway.
Ma R, Zhao LN, Yang H, Wang YF, Hu J, Zang J, Mao JG, Xiao JJ, Shi M. Ma R, et al. Am J Transl Res. 2018 Dec 15;10(12):4130-4140. eCollection 2018. Am J Transl Res. 2018. PMID: 30662656 Free PMC article. - Second-line treatment of metastatic prostatic carcinoma.
Newling DW. Newling DW. Urol Res. 1997;25 Suppl 2:S73-8. doi: 10.1007/BF00941992. Urol Res. 1997. PMID: 9144891 Review. - Increased frequencies of gene and chromosome mutations after X-irradiation in mouse embryonal carcinoma cells transfected with the bcl-2 gene.
Taga M, Shiraishi K, Shimura T, Uematsu N, Oshimura M, Niwa O. Taga M, et al. Jpn J Cancer Res. 2000 Oct;91(10):994-1000. doi: 10.1111/j.1349-7006.2000.tb00876.x. Jpn J Cancer Res. 2000. PMID: 11050469 Free PMC article. - Antitumor activity and downregulation of pro-angiogenic molecules in human prostate cancer cells by a novel thiazolidione compound.
Teraishi F, Wu S, Inoue S, Zhang L, Davis JJ, Guo W, Dong F, Fang B. Teraishi F, et al. Prostate. 2006 Mar 1;66(4):430-8. doi: 10.1002/pros.20373. Prostate. 2006. PMID: 16302260 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous